logo

Health Care News

Share

AstraZeneca Amends Collaboration With Ironwood For Linzess In China

FDA Grants Breakthrough Therapy Designation For Genentech's Gazyva

Novartis 16-week Phase III PREVENT Study Of ASAS40 Meets Primary Endpoint

AstraZeneca: FDA Grants Fast Track Designation For FARXIGA In Heart Failure

AlivaMab Discovery Services Announces Multi-Target Agreement With Janssen